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Abstract
Background Laparoscopic Roux-en-Y gastric bypass
(RYGB) has become the procedure of choice for the treat-
ment of morbid obesity. Recently, several reports have
shown the potential advantages of the robotic approach,
notably by reducing complications. The aim of this study is
to report our long-term experience with robotic Roux-en-Y
gastric bypass (RYGB) and to compare outcomes with the
laparoscopic approach.
Methods From January 2003 to September 2013, 777 consec-
utive minimally invasive RYGB have been performed in our
institution: 389 laparoscopically (50.1 %) and 388 robotically
(49.9 %). During the study period, all the data regarding these
consecutive RYGB has been prospectively collected in a
dedicated database.
Results While longer in duration compared to laparoscopy (+
30 min; p=0.0001), the robotic approach had a lower conver-
sion rate (0.8 vs. 4.9 %; p=0.0007), and less complications
(11.6 % vs. 16.7%; p=0.05), in particular, less gastrointestinal
leaks (0.3 vs. 3.6 %; p=0.0009). There were also less early
reoperations (1 vs. 3.3 %; p=0.05) and a shorter hospital stay
in the robotic group (6.2 vs. 10.4 days; p=0.0001). There were
no statistical differences between the early and the current
robotic experience, except in operative time and hospital stay,
which were shorter for the last 100 cases. Finally, the BMI loss
was significantly higher in the laparoscopic group starting at
the first post-operative year.
Conclusions Robotic RYGB is not only safe and feasible, but
also a valid option in comparison to laparoscopy. At the cost
of a longer operative time, we observed better short-term
outcomes with the robotic approach.
Keywords Robot .Laparoscopy .Gastric bypass .Long-term
follow up .Weight loss
Introduction
Twenty years after the first laparoscopic Roux-en-Y gastric
bypass (RYGB) [1], it has become the gold standard bar-
iatric intervention [2, 3], at least in a majority of bariatric
centers. Large series have reported not only good peri-
operative outcomes, but also very adequate long-term and
sustainable weight loss [4, 5]. In addition, RYGB has been
shown to resolve a majority of obesity-related comorbidi-
ties such as diabetes, hypertension, and obstructive sleep
apnea syndrome [6, 7].
Even if the complication rate following laparoscopic
RYGB is relatively low, the risk of developing a gastrointes-
tinal leak is still reported up to 5.2 % [8, 9]. A leak remains as
the most dreadful complication after a RYGB, explaining why
potential risk factors are still under investigation in order to
minimize this risk.
In parallel, robotics has been developed to expand
the indications of minimally invasive surgery. Since the
early 2000s, robotic surgery has been reported feasible
and safe, even for advanced and complex procedures
[10]. In bariatric surgery, the robotic technology has
been introduced successfully, as reported by several
centers [11–15]. Specifically for RYGB, the experience
is also positive with a possible reduction of anastomotic
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complications, as confirmed in recent systematic reviews
[16–18]. However, the interest remains relatively limited
to a few centers, possibly due to the lack of large
comparative studies.
The aim of our study was to report our long-term experi-
ence with robotic RYGB in a teaching institution and to
compare the outcomes with the laparoscopic approach.
Material and Methods
From January 2003 to September 2013, 777 consecutive
minimally invasive RYGB have been performed in our insti-
tution: 389 with a laparoscopic approach (50.1 %) and 388
using a robotic approach (49.9 %). During the study period, all
the data from the consecutive RYGB has been prospectively
collected in a dedicated database.
Of note, we acquired the standard robotic system in 2006
(da Vinci Surgical system, Intuitive Surgical, Sunnyvale, CA)
and started robotic RYGB in July 2006 (Fig. 1). Later, the
robotic system was upgraded to a da Vinci S system, and
finally in 2010 to the da Vinci Si system.
All the procedures were performed by different expe-
rienced laparoscopic and robotic surgeons (>100 ad-
vanced cases of minimally invasive/bariatric surgery
each). Patients included in the bariatric program met the
criteria of the Swiss Society for the Study of Morbid
Obesity and Metabolic Disorders [19]. All patients
underwent a routine preoperative endoscopy as well as a
multidisciplinary evaluation including a psychiatric as-
sessment. There were no specific selection criteria for
robotics. The exclusion criteria were the same for both
groups (anesthesiological contraindication, evident hostile
abdomen). There was no randomization. The choice of the
approach was based on the availability of the system.
The follow-up was organized by a research nurse
especially dedicated to the bariatric program according
to our national guidelines.
Surgical Technique
The surgical technique was standardized and similar between
the groups.
The pneumoperitoneum was created using an OPTIVIEW
(Endopath Xcel, Ethicon) technique. All patients underwent a
routine cholecystectomy.
A small gastric pouch (around 20–30 cm3) was created
using blue or green cartridge staplers. A standard RYGB with
a 150-cm alimentary limbwas constructed after the creation of
the gastric pouch. In case of robotic approach, a hand-sewn
gastrojejunal (GJ) and jejunojejunal (JJ) anastomosis was
performed, using a single layer running suture of 2.0 Vicryl
(Ethicon). The technique was already described in details
elsewhere [12, 20].
For the laparoscopic cases, a mechanical circular anas-
tomosis was preferred with a transorally inserted anvil.
Recently, we started to perform linear GJ anastomosis as
well. The jejunojejunal anastomosis was performed with a
linear stapler.
A routine air leak test was performed at the end of the
procedure. A drain was left close to the GJ anastomosis
depending on the surgeon’s preference.
Postoperative Management
At the beginning of our experience, patients underwent a
routine postoperative liquid contrast swallow at postoper-
ative day (POD) 2. If considered normal, a liquid diet was
initiated on POD 3 and puree diet on POD 4. More
recently, we decided not to perform an upper gastrointes-
tinal series and to initiate a liquid diet on POD 1, accord-
ing to our published decisional algorithm [21]. If liquid
diet was tolerated on POD 1, patients were advanced to
puree diet on POD 2.
They were followed postoperatively at our outpatient clinic
at 1, 3, 6, 12, and 18 months, and annually thereafter.
Fig. 1 Evolution of minimally
invasive RYGB through
September 2013
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Data Studied
We evaluated the peri-operative outcomes between both
groups. The operative time was defined as the time between
the first skin incision and the last skin closure. A conversion
was defined as the need to finish the procedure by another
approach than the initial one.
We evaluated the 30-day mortality and morbidity, using the
Clavien-Dindo classification to grade complications [22].
Regarding weight loss, the percent of BMI loss (%BMI
loss) was defined as the operative BMI minus the follow-up
BMI, divided by the operative BMI.
The percent of excess BMI loss (%EBMIL) was
defined as: 100 – ((follow-up BMI−25)/(beginning
BMI−25)×100), where 25 is defined as the limit of a
normal BMI [23].
Statistical Analysis
The results of parametric and nonparametric data were
expressed as mean±standard deviation (SD) and median
(range), respectively. GraphPad Software (GraphPad, La
Jolla, CA) was used for all statistical analyses. Confidence
intervals were set at 95 %. A two-sided p value of ≤0.05 was
considered as statistically significant. Comparisons between
both groups were determined using Fisher’s exact test for
discrete variables and Student’s t test for continuous variables.
Results
During the study period, 777 patients underwent a minimally
invasive RYGB, 389 by laparoscopy (50.1 %) and 388 by a
robotic approach (49.9 %). Patients’ demographics are sum-
marized in Table 1.
There were more male patients in the robotic group, but the
difference did not reach statistical significance. On the other
hand, patients in the laparoscopic group were slightly younger
(42 vs. 43.8 years old for robotics; p=0.02) and had a higher
preoperative BMI (+0.8 kg/m2; p=0.05). There were no dif-
ferences in terms of American Society of Anesthesiologists
(ASA) score or comorbidities.
Peri-Operative Outcomes
The operative time for the robotic approach was longer than
laparoscopy (+30 min; p=0.0001) (Table 2). On the other
hand, there were less conversions in the robotic group in
comparison with laparoscopy (0.8 vs. 4.9 %; p=0.0007). We
observed three conversions in the robotic group: one because
of a stapler misfire, one because of a non-reducible large hiatal
hernia, and finally, one because of severe intra-abdominal
adhesions. In the laparoscopic group, 19 conversions were
observed: 4 due to severe adhesions, 4 because of a very large
left liver lobe, 2 because of difficulties in maintaining an
adequate pneumoperitoneum, 1 because of a duodenal injury
during the insertion of the initial trocar, and 8 for other various
technical problems (for example, stapler misfire).
The intra-operative complication rate was similar in both
groups. We had three intra-operative complications in the
robotic group. These were a stapler misfiring as mentioned
before and an intraoperative perforation of the gastric pouch
by the nasogastric tube requiring a robotic redo of the pouch.
Finally, one patient presented an intraoperative bronchospasm.
In addition, we observed six intra-operative complications
in the laparoscopic group. One patient presented an esopha-
geal lesion during the dissection that was immediately identi-
fied and repaired. One patient presented a massive broncho-
spasm during intubation. One leak was found during the air
leak test. One patient presented a duodenal injury during the
introduction of the first trocar. One stapler misfire required a
conversion to open surgery. And finally, one patient had a
paravenous perfusion causing an upper limb compartment
syndrome, requiring a fasciotomy.
There was one perioperative death (grade V) in each group
(p=1). In the robotic group, a 40-year-old lady was classified
ASA 3 and had a BMI of 44. Her past medical history was
significant for a coagulopathy, and unfortunately, at postoper-
ative day 1, she suffered a massive pulmonary embolism and a
complete bilateral carotid thrombus. She was immediately
treated by endovascular thromboaspiration. Unfortunately,
she developed a massive reperfusion cerebral edema and
passed away at postoperative day 2. In the laparoscopic group,
a 45-year-old lady (ASA 3, BMI 57) developed an early
postoperative respiratory distress, caused by an undiagnosed
obstructive sleep apnea syndrome. Despite mechanical venti-
lation and intensive care, a cerebral anoxia developed and she
passed away on postoperative day 3.
Regarding postoperative morbidity, there were less com-
plications in the robotic group (11.6 %) in comparison with
laparoscopy (16.7 %; p=0.05) (Tables 2 and 3).
In the robotic group, we observed 45 complications, with a
majority of grades I and II (73.3 %). We observed 11 grade I
complications: anastomotic edemas (n=3; requiring a delay in
postoperative diet), peripheral paresthesias (n=3; successfully
treated conservatively), atelectasis (n=2), and wound prob-
lems (n=3; hematoma, abscess, and delayed wound healing).
Regarding grade II complications, we observed: pulmonary
embolism (n=12) and deep venous thrombosis (n=2), bacter-
emia (n=3; requiring intravenous antibiotics), urinary tract
infections (n=2; requiring antibiotics), peripheral neuropathy
(n=1), hematemesis (n=1; necessitating transfusion), and
deep parietal abscess (n=1; requiring oral antibiotics). In
addition, we observed five grade IIIb complications: four of
them required a reoperation as mentioned later. In addition,
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one patient presented a bleeding anastomotic ulcer requiring
endoscopic hemostasis. Finally, we observed six grade IVa
complications: respiratory failure (n=3; requiring a prolonged
intubation in the intensive care unit (ICU)), severe pneumonia
(n=1; necessitating intubation), pulmonary embolism (n=1;
requiring 5 days of monitoring in the ICU), and laryngeal
edema (n=1; necessitating prolonged intubation).
In the laparoscopic group, 65 complications were recorded.
The majority were grades I and II (69.2 %). Regarding grade I
complications, we observed: wound abscess (n=8), self-limited
GJ leak (n=5; treated conservatively without removing the
drain), atelectasis (n=2), bile leak following a liver biopsy (n=
1; treated successfully by keeping the drain in place), phlebitis
(n=1), postoperative agitation (n=1), and edema at the level of
the GJ (n=1; delaying the postoperative diet). Regarding grade II
complications, we observed: pulmonary embolisms (n=8) and
deep venous thrombosis (n=1), gastrointestinal bleeding (n=4;
requiring only blood transfusion and monitoring), urinary tract
infection (n=4; necessitating oral antibiotics), pneumonias (n=
4), intra-abdominal abscess (n=2; requiring intravenous
antibiotics), heparin-induced thrombocytopenia (n=1; requiring
oral anticoagulation), acute pulmonary edema (n=1; necessitat-
ing oral diuretics and physiotherapy), and diarrhea with positive
culture for Clostridium difficile (n=1). Twelve grade III compli-
cations were observed. Three of them were graded IIIa: one
duodenal leak after subtotal gastrectomy during the RYGB (re-
section for multiple polyps) requiring a radiological drainage.
One pulmonary embolism necessitated a vena cava filter.
And finally, one bile leak (from a liver biopsy) was
diagnosed and required radiological drainage. Nine grade
IIIb complications were also observed; all of them re-
quired a reoperation as discussed later. Seven grade IV
complications were reported. Two were graded IVa: one
respiratory insufficiency requiring intubation, and one
prolonged intubation in the ICU for another patient.
Finally, five complications were graded IVb: four of
them due to a gastrointestinal leak with septic shock
requiring a reoperation as mentioned below. Another
patient presented a pulmonary embolism with acute re-
spiratory distress, associated with kidney failure.
Table 1 Patients’ demographics
Robotic (n=388) Laparoscopy (n=389) p value
Gender 0.09
Male 104 84
Female 284 305
Age in years, mean±SD 43.8±10.7 42±10.4 0.02
BMI in kg/m2, mean±SD 44±5.2 44.8±6.2 0.05
Weight in kg, mean±SD 122.1±20.7 122.8±21.5 0.64
ASA score, mean±SD 2.3±0.5 2.3±0.5 1
Comorbidity
Diabetes 81 (20.9 %) 86 (22.1 %) 0.72
Hypertension 135 (34.8 %) 131 (33.7 %) 0.76
Sleep apnea syndrome 106 (27.3 %) 85 (21.9 %) 0.6
SD standard deviation, BMI body mass index, ASA American Society of Anesthesiology
Table 2 Perioperative outcomes
Robotic (n=388) Laparoscopy (n=389) p value
Operative time in minutes, mean±SD 245±93.6 215.8±69.1 0.0001
Conversion rate 3 (0.8 %) 19 (4.9 %) 0.0007
Intraoperative complications 3 (0.8 %) 6 (1.5 %) 0.5
Postoperative complications 45 (11.6 %) 65 (16.7 %) 0.05
Gastrointestinal leak 1 (0.3 %) 14 (3.6 %) 0.0009
Pulmonary embolism 17 (4.4 %) 9 (2.3 %) 0.12
30-day mortality 1 (0.3 %) 1 (0.3 %) 1
Reoperations 4 (1 %) 13 (3.3 %) 0.05
Length of stay in days, mean±SD 6.2±4.8 10.4±17.5 0.0001
SD standard deviation
Italic numbers were given for statistically significant comparisons
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In addition, there were less early reoperations in the
robotic groups (1 %) in comparison with laparoscopy
(3.3 %; p=0.05). In the robotic group, we observed four
reinterventions: one due to a staple line bleed, one
because of an incarcerated port site hernia, one because
of a late GJ leak (at POD 13 after a large meal), and
one for a suspected infected hematoma. In the laparo-
scopic group, we found 13 reoperations. Eight of them
were performed for intestinal leaks (four JJ anastomotic
leaks, three GJ anastomotic leaks, and one at the level
of the remnant stomach). One patient underwent a re-
operation for suspicion of intestinal leak, but with no
intra-operative finding. We noticed one reoperation for
an incarcerated port site hernia at POD 3, leading to a
GJ blowout because of the overpressure. One patient
presented a cystic duct leak on POD 1, requiring a
reoperation. One patient underwent a reoperation for a
large hematoma, necessitating exploratory laparoscopy
and drainage. Finally, one patient presented a kinking at
the level of the common intestinal limb, resulting in a
mechanical ileus requiring a reoperation and remnant
gastrostomy.
Effect of the Learning Curve
We chronologically divided our robotic and laparoscopic
cases in groups of 100 patients. When comparing our
initial cases with our current experience, we found no
differences in terms of complications, reoperation, and
mortality rates (Table 4). On the other hand, there was a
strong statistical difference in operative time: minus 2 h
for the comparison between the first 100 robotic cases and
the last 100 robotic cases (p=0.0001). Similarly, the dif-
ference between the last 100 laparoscopic cases and the
last 100 robotic cases tends to disappear (only a difference
of 18 min; p=0.06). There were fewer conversions in the
last robotic cases in comparison with the last laparoscopic
cases as well (0 vs. 8 %; p=0.007). Finally, there was a
shorter hospital stay for the robotic group in comparison
to laparoscopy, whatever the studied period.
Effect on the Body Mass Index
The maximum BMI loss was observed at 24 months
(Table 5). It is interesting to note that the laparoscopic
group tends to present a higher BMI loss, a higher
percent BMI loss, and a higher percent excess BMI loss
in comparison to the robotic group.
Discussion
A decade after the first robotic bariatric procedure, robotics is
still looking to find its place in the bariatric surgeon’s arma-
mentarium. The feasibility and the safety of the robotic ap-
proach have been clearly established not only for RYGB
[11–15], but also for gastric banding [24], sleeve gastrectomy
[25], and duodenal switch [26]. Despite these encouraging
reports, part of the surgical community still awaits stronger
evidence of benefits of the robotic technique. Recently, sev-
eral systematic reviews reported at least similar [18, 27], if not
better [16, 17], postoperative outcomes thanks to the robotic
technology. In addition, other possible advantages were re-
ported: the learning curve could be shortened [13, 18, 20, 28,
29], the cost could be minimized in some centers [12, 21], and
particularly difficult procedures such as for superobese pa-
tients [30] and revisional procedures [17, 31, 32] can be
performed safely.
In summary, we report herein one of the largest compara-
tive studies, evaluating the robotic and laparoscopic ap-
proaches. In addition, this series presents one of the longest
follow-ups to date. The lessons learned from this large expe-
rience are important, and the adoption of the robotic technol-
ogy in our center allows us to improve our outcomes. These
results tend to be within the range of other comparative series
(Table 6). Undoubtedly, the operative time for the robotic
approach remains longer than standard laparoscopy, even if
recent systematic reviews failed to show any differences [16,
27]. While this difference tends to disappear with time, this
phenomenon was almost uniformly reported in other series
[12, 28, 33, 36–38]. A longer operative time can be explained,
at least in part, by the addition of the docking time and the
need to change instruments regularly.
More interestingly, the conversion rate can be significantly
reduced (less than 1 % for robotic versus almost 5 % for
laparoscopy). Beyond the possible effect of the learning curve,
robotics could help to minimize the risk of conversion, as
reported for other indications [39]. More interestingly, the
complication rate can be reduced thanks to the robotic tech-
nology, especially the risk of anastomotic leak. In our series,
we observed only one late GJ leak and no JJ leak in the robotic
group, in comparison to 13 GJ and JJ leaks in the laparoscopic
group. Even if the clinical significance of several leaks in the
Table 3 30-Day postoperative complications according to Clavien-
Dindo classification [22]
Grade Robotic (n=45) Laparoscopy (n=65) p value
I 11 19 0.66
II 22 26 0.4
IIIa 0 3 0.27
IIIb 5 9 0.77
IVa 6 2 0.06
IVb 0 5 0.08
V 1 1 1
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laparoscopic group was limited (successful conservative treat-
ment), a robotic hand-sewn anastomosis seems safer than a
laparoscopic mechanical one. This reduced risk was also
reported by other groups [12, 14, 28, 29]. To illustrate, Tieu
et al. [11] found an anastomotic leak rate of only 0.09 % in the
largest robotic series to date. In addition, in a large compara-
tive study, Snyder et al. [14] reported a significant difference
in terms of anastomotic leaks. Indeed, they found no leak in
the robotic group versus 1.7 % of leakage in the laparoscopic
group (p=0.05).
On the other hand, the risk of pulmonary embolism was
almost twice as high following robotic approach in compari-
son with laparoscopy. This could be explained by a longer
operative time in the robotic group, as management and
prophylaxis was otherwise similar between both groups. Fi-
nally, in terms of potential advantages, we observed fewer
reoperations (threefold reduction) and a shorter hospital stay
(minus 4 days) in the robotic group. These findings are con-
sistent with the current robotic literature (Table 6), even if less
evident in other series. Moreover, the effect of the learning
Table 4 Differences between the first 100 cases and the last 100 cases
Robotic first 100 cases Robotic last 100 cases Laparoscopy first 100 cases Laparoscopy last 100 cases p value
Operative time 335±97.3 217±79.4 269±80.6 199±51.9 0.0001*
Conversion rate 2 (2 %) 0 4 (4 %) 8 (8 %) NS**
Intra-operative complications 0 1 (1 %) 0 3 (3 %) NS
Postoperative complications 15 (15 %) 12 (12 %) 16 (16 %) 16 (16 %) NS
Leak 0 1 (1 %) 5 (5 %) 3 (3 %) NS
PE 6 (6 %) 4 (4 %) 2 (2 %) 3 (3 %) NS
Mortality 0 0 0 1 (1 %) NS
Reoperation 1 (1 %) 2 (2 %) 4 (4 %) 5 (5 %) NS
Length of stay 8±2.7 6±8.3 13±20.9 9±11.6 <0.05***
Expressed in mean±standard deviation
PE pulmonary embolism, NS not significant
*Highly statistically significant, except for the comparison between 100 last robotic cases and 100 last laparoscopic cases (p=0.06)
**Statistically significant between 100 last robotic cases and 100 last laparoscopic cases (p=0.007)
***Statistically significant, except the comparison between 100 first laparoscopic cases and 100 last laparoscopic cases (p=0.1)
Table 5 Evolution of body mass index
Robotic group Laparoscopic group p value
Number of patients at 1 month 343 353
BMI loss at 1 month, mean±SD 4.8±1.6 5±1.8 0.12
Percent BMI loss at 1 month (%), mean±SD 10.9±3.3 11.1±3.6 0.44
Percent excess BMI loss at 1 month (%), mean±SD 26.2±9 26.3±9.2 0.89
Number of patients at 12 months 257 280
BMI loss at 12 months, mean±SD 14.7±4.2 15.9±3.9 0.0007
Percent BMI loss at 12 months (%), mean±SD 33.3±8.5 35.5±7 0.001
Percent excess BMI loss at 12 months (%), mean±SD 79.7±23.1 83.9±19 0.02
Number of patients at 24 months 140 219
BMI loss at 24 months, mean±SD 15.3±4.4 17.1±5.5 0.001
Percent BMI loss at 24 months (%), mean±SD 34.7±8.2 37.8±10.1 0.002
Percent excess BMI loss at 24 months (%), mean±SD 83.5±21.1 87.4±25 0.12
Number of patients at 36 months 75 175
BMI loss at 36 months, mean±SD 13.8±4.2 16.1±4.8 0.0004
Percent BMI loss at 36 months (%), mean±SD 31.5±8.7 35.8±8.3 0.0003
Percent Excess BMI loss at 36 months (%), mean±SD 75.2±22 83.6±19.5 0.003
BMI body mass index, SD standard deviation
Italic numbers were given for statistically significant comparisons
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curve was low, since only the operative time and the length of
stay were different between the early and the most recent
experience.
A new element remains: the difference between both
groups in terms of BMI loss. Indeed, the laparoscopic
group presented a higher BMI loss. While this was a
surprise for our group, several reasons might be hypoth-
esized. Even if the technique was similar between both
approaches, a couple of differences exist: first, the anas-
tomosis was hand-sewn with absorbable sutures in the
robotic group and could be less obstructive than a circular
mechanical anastomosis, especially in the long term. In-
deed, the effect of the stoma diameter is known to be a
potential risk factor for weight regain [40]. Thus, we are
evaluating a calibration of the GJ anastomosis in order to
avoid too-large stoma. In addition, the length of the ali-
mentary limb might be shorter in the robotic group. In-
deed, the enlarged three-dimensional vision could render
the measurement of the alimentary limb more difficult
than in the standard laparoscopic group. In order to try
and correct this hypothetical parameter, we have now
started measuring the length of the different segments
with an umbilical tape or a marked instrument. On the
other hand, Park et al. [37] did not find any significant
differences in terms of weight loss at 1 year after
robotic RYGB.
Clearly, in 2013, the real question is to determine the
best indications for the robotic technology. The present
series gives encouraging results, showing positive short-
term outcomes with diminished leak rate. Despite these
promising results, robotics still has some difficulties in
establishing itself as the gold standard approach. Several
reasons have been proposed to tentatively explain this
fact. First, skeptical readers might argue that only few
evidences and controversial results are available to date.
In fact, several comparative studies (Table 6) were pub-
lished and reported good outcomes after a robotic ap-
proach. More interesting, the majority of these series
have shown clear advantages of using the robotic tech-
nology, as confirmed by systematic reviews [16, 18].
Table 6 Comparative series (>10 patients) evaluating robotic and laparoscopic RYGB
Authors Approach Number ORT Conversion (%) Complications (%) Leaks (%) LOS
Artuso et al. [33] R 41 289 NA NA <3 NA
L 120 174 NA NA <3 NA
Ayloo et al. [13] R 90 207 0 2.2 0 2
L 45 227 0 11* 0 3
Benizri et al. [34] R 100 130 3 24 3 9.3
L 100 147 1 21 0 6.7
Curet et al. [35] R 21 181.7 NA 14.3 NA 3
L (sutured) 36 183.3 NA 16.7 NA 3.3
L (stapled) 78 185.6 NA 19.2 NA 3.6
Hagen et al. [12] R 143 293 1.4 16.1 0 7.4
L 323 206 4.9 18 4 11
Hubens et al.[28] R 45 212 20 6.7 0 4.7
L 45 127 0 13.3 4.4 4.7
Myers et al. [36] R 100 144 0 NA 1 1.5
L 100 87 0 NA 1 2.2
Mohr et al. [29] R 10 169 40 20 0 NA
L 10 208 50 20 10 NA
Park et al. [37] R 105 169 1 9.5 1.9 3.4
L 195 152 1.5 9.7 2.1 3
Sanchez et al. [15] R 25 130.8 0 0 0 2.9
L 25 149.4 0 0 0 2.6
Scozzari et al. [38] R 110 247.5 0 16.4 1.8 7.8
L 423 187 NA NA 1.9 8.3
Snyder et al. [14] R 320 192 NA 22.5 0 2.7
L 356 NA NA 21.6 1.7 3
R robotic, L laparoscopic, ORT operative time in minutes, LOS length of stay in days, NA not available
*Including late complications
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With a cumulative experience of more than 1,800 ro-
botic RYGB reported in the literature, the robotic ap-
proach can be considered as safe, feasible, and a valid
option, especially for difficult cases. Indeed, as men-
tioned earlier, revisional procedures, which are typically
challenging, can be performed safely [31] and with
better outcomes in comparison to open or laparoscopy
[32]. Super obese patients, with a higher peri-operative
risk, could be another good indication, notably by re-
ducing the torque effect and allowing the surgeon to
work in a deep and narrow space [30].
On the other hand, criticisms have been raised concerning
the excessive costs of the robotic technology [41]. In the
bariatric field, we have recently reported our cost analysis that
showed a clear advantage of the robotic approach, notably by
reducing complications [12] and by minimizing the need of
postoperative radiological examinations [21]. Other groups
have also found similar total hospital charges [37]. However,
these findings were not confirmed by other series that show
higher costs [28, 35, 38]. Recently, Bailey et al. [27] per-
formed a systematic review and economic analysis showing
that the expected costs for robotic RYGB were higher than
that for laparoscopy. More data is clearly required to evaluate
the exact economical role of robotics in bariatric surgery.
While bringing new data, this study has several limitations
that require comments. First, by its non-randomized nature,
this series remains only a large prospective comparative study.
Different periods of time and different surgeons were taken
into consideration. Yet, we used the same standardized tech-
nique, reproducible in a teaching institution. Globally, there
were no significant differences between the various periods
considered, except for the operative time and the length of stay
(effect of the learning curve?).
Then, even if standardized, the technique between both
groups was not exactly the same. Indeed, the anastomotic
technique was different: mechanical versus hand-sewn. This
bias [42] could explain, at least in part, the difference of
outcomes. Indeed, Ayloo et al. [13] have reported a hand-
sewn anastomotic technique in both groups, with similar
results, except an operative time shorter for the robotic group.
We also note that our laparoscopic operative time remains
typically longer than previously reported (Table 6).
Conclusions
We present herein one of the largest robotic series with long-
term follow-up. We have shown that robotic RYGB is not
only safe and feasible, but also a valid option in comparison to
laparoscopy. At the price of a longer operative time, we
observed better short-term outcomes after a robotic approach.
On the other hand, the long-term outcomes regarding the BMI
loss were surprisingly in disfavor of the robotic approach,
motivating a modification of our technique (measurement of
the alimentary limb, calibration of the GJ anastomosis).
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